Inventor · disambiguated record
Harald Heidecke
Also filed as: HEIDECKE HARALD
11 granted patents·6 pending applications·2 citations·filing 2002–2022
79Inventor score
Top patents by PatentIndex Score
17 records- 0165US8425877B2Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibodySCHULZE-FORSTER KAI·Filed 2007·Granted Apr 23, 2013·1 cites·13 claims
- 0260US8592164B2Method for diagnosis of a disease involving an anti-endothelin-receptor antibodySCHULZE-FORSTER KAI·Filed 2007·Granted Nov 26, 2013·1 cites·9 claims
- 0355US2025283892A1Diagnosis of alzheimer's disease by detecting auto-antibodies against y-box binding protein-1 (yb-1)CELLTREND GMBH·Filed 2022·Application pending·0 cites
- 0447US2022276251A1Diagnosis of cancer using detection of antibodies directed against pd1 and pd-l1CELLTREND GMBH·Filed 2020·Application pending·0 cites
- 0544US8999338B2Method for diagnosis for multiple sclerosis involving anti1-receptor antibodyHEIDECKE HARALD·Filed 2011·Granted Apr 7, 2015·0 cites·11 claims
- 0643US10732184B2Diagnosis of cancer by detecting auto-antibodies against PAR1CELLTREND GMBH·Filed 2015·Granted Aug 4, 2020·0 cites·25 claims
- 0743US10191058B2Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor receptor (VEGFR)CELLTREND GMBH·Filed 2015·Granted Jan 29, 2019·0 cites·14 claims
- 0842US10739346B2Diagnosis of cancer by detecting auto-antibodies against EGF-receptorCELLTREND GMBH·Filed 2015·Granted Aug 11, 2020·0 cites·13 claims
- 0942US10203343B2Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (EGF)CELLTREND GMBH·Filed 2015·Granted Feb 12, 2019·0 cites·9 claims
- 1039US8846324B2In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptorHEIDECKE HARALD·Filed 2011·Granted Sep 30, 2014·0 cites·18 claims
- 1138US8110374B2Method for predicting the risk of transplant rejection and immunological testkitSCHULZE-FORSTER KAI·Filed 2002·Granted Feb 7, 2012·0 cites·3 claims
- 1237US10802020B2Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptorCELLTREND GMBH·Filed 2016·Granted Oct 13, 2020·0 cites·11 claims
- 1337US2021311048A1Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host diseaseCELLTREND GMBH·Filed 2017·Application pending·0 cites
- 1437US2019250172A1Prognosis of adverse outcomes by determination of midkine levels after cardiovascular stressCELLTREND GMBH·Filed 2016·Application pending·0 cites
- 1535US10261087B2Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (VEGF)CELLTREND GMBH·Filed 2015·Granted Apr 16, 2019·0 cites·3 claims
- 1635US2018284117A1Method for diagnosing APS using determination of anti-PAR1 antibodiesCELLTREND GMBH·Filed 2016·Application pending·0 cites
- 1734US2017328898A1Diagnosis of an autoimmune disease using detection of antibodies directed against c5a-receptorCell Trend GmbH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harald Heidecke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →